Yi-Chih Wang

Dr. Yi-Chih Wang


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2010 in JACC
Verified
Journal Article
Closed access
Chia-Ti TsaiChia-Ti Tsai
Chia-Ti Tsai
FCFu-Tien Chiang
Fu-Tien Chiang
CTChuen-Den Tseng
Chuen-Den Tseng
JHJuey-Jen Hwang
Juey-Jen Hwang
KKKuan-Ting Kuo
Kuan-Ting Kuo
JLJiunn-Lee Lin
Jiunn-Lee Lin

23 November 2011 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
YWYen-Wen Wu
Yen-Wen Wu
HKHsian-Li Kao
Hsian-Li Kao
CHChi-Lun Huang
Chi-Lun Huang
MCMing-Fong Chen
Ming-Fong Chen
LLLian-Yu Lin
Lian-Yu Lin
WYWei-Shiung Yang
Wei-Shiung Yang

1 September 2015 in Circulation: Heart Failure
Verified
Journal Article
Closed access
PDF file
YWYi-Chih Wang
Yi-Chih Wang
CLChang-Seng Liang
Chang-Seng Liang
DGDeepa M. Gopal
Deepa M. Gopal
NANir Ayalon
Nir Ayalon
CDCourtney Donohue
Courtney Donohue
JHJennifer E. Ho
Jennifer E. Ho
Background—: Despite the substantial overlap of obesity and metabolic disease, there is heterogeneity with respect to cardiovascular risk. We sought to investigate preclinical differences in systolic and diastolic function in obesity, and specifically compare obese individuals with and without metabolic syndrome (MS). Methods and Results—: Obese individuals without cardiac disease with (OB/MS+, n=124) and without (OB/MS−, n=37) MS were compared with nonobese controls (n=29). Diastolic function was assessed by transmitral and tissue Doppler. Global longitudinal strain (LS) and time-based dyssynchrony were assessed by speckle tracking. Both OB/MS− and OB/MS+ groups had similar ejection fraction but worse systolic mechanics as assessed by LS and dyssynchrony when compared with nonobese controls. Specifically, OB/MS− had 2.5% lower LS (SE, 0.7%; P =0.001 in multivariable-adjusted analyses) and 10.8 ms greater dyssynchrony (SE, 3.3 ms; P =0.002), and OB/MS+ had 1.0% lower LS (SE, 0.3%; P <0.001) and 7.8 ms greater dyssynchrony (SE, 1.5 ms; P <0.001) when compared with controls. Obesity was associated with impaired diastolic function regardless of MS status, as evidenced by greater left atrial diameter and left ventricular mass although diastolic dysfunction was more pronounced in OB/MS+ than in OB/MS− individuals. Conclusions—: Obesity is associated with subclinical differences in both systolic and diastolic function regardless of the presence or absence of MS although MS seems to be associated with worse diastolic dysfunction. When compared with controls, metabolically healthy obese had lower LS, greater dyssynchrony, and early diastolic dysfunction, supporting the notion that obesity per se may have adverse cardiovascular effects regardless of metabolic disease.

1 March 2013 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
YWYi-Chih Wang
Yi-Chih Wang
CYChih-Chieh Yu
Chih-Chieh Yu
FCFu-Chun Chiu
Fu-Chun Chiu
Chia-Ti TsaiChia-Ti Tsai
Chia-Ti Tsai
LLLing-Ping Lai
Ling-Ping Lai
JLJiunn-Lee Lin
Jiunn-Lee Lin

19 February 2015 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
Chia-Ti TsaiChia-Ti Tsai
Chia-Ti Tsai
CWCHOKAI WU
CHOKAI WU
JLJen-Kuang Lee
Jen-Kuang Lee
SCSheng-Nan Chang
Sheng-Nan Chang
YKYu-Min Kuo
Yu-Min Kuo
JLJiunn-Lee Lin
Jiunn-Lee Lin
TNF-alpha (TNF-α) causes left ventricular diastolic dysfunction. Down-regulation of sarcoplasmic reticulum Ca2+-ATPase 2a protein (SERCA2a) expression is one of the major mechanisms underlying diastolic dysfunction. We investigated whether TNF-α modulates SERCA2a expression and alters cardiac diastolic function, and its detailed signalling pathway. We used both in vitro cellular cardiomyocyte model and in vivo rat model to address this issue. We found that TNF-α decreased the levels of both SERCA2a mRNA and protein in the cardiomyocytes, with corresponding impairment of diastolic calcium reuptake, a cellular phenotype of cardiac diastolic function. An ∼2 kb promoter of the SERCA2a gene (atp2a2) along with its serial deletions was cloned into the luciferase reporter system. TNF-α significantly decreased the promoter activity, and truncation of the SERCA2a gene promoter with the putative nuclear factor kappa-B (NF-κB) response element abolished TNF-α-induced SERCA2a gene suppression. Chromatin immunoprecipitation and gel retardation also confirmed the binding of NF-κB to this putative-binding site. TNF-α increased the phosphorylation of IKK and the degradation of IκB, resulted in NF-κB nuclear translocation, and decreased SERCA2a gene promoter activity. This process was attenuated by NF-κB blockers and simvastatin. In the in vivo rat model, lipopolysaccharide treatment significantly elevated the serum TNF-α level, as well as phosphorylation of IKK, resulting in a decrease in myocardial SERCA2a expression, diastolic calcium reuptake, and diastolic dysfunction. Oral treatment with simvastatin led to an increase in SERCA2a expression, alleviation, and prevention of the diastolic dysfunction. TNF-α suppresses SERCA2a gene expression via the IKK/IκB/NF-κB pathway and binding of NF-κB to the SERCA2a gene promoter, and its effect is blocked by simvastatin, demonstrating the potential therapeutic effect of statins in treating inflammation-related diastolic dysfunction.

5 December 2010 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
Chia-Ti TsaiChia-Ti Tsai
Chia-Ti Tsai
CTChuen-Den Tseng
Chuen-Den Tseng
JHJuey-Jen Hwang
Juey-Jen Hwang
CWCHOKAI WU
CHOKAI WU
CYChih-Chieh Yu
Chih-Chieh Yu
JLJiunn-Lee Lin
Jiunn-Lee Lin
We investigated the molecular mechanism of rapid-depolarization-induced atrial fibrosis. We used a direct atrial myocyte–fibroblast contact co-culture and a fibroblast-specific transforming growth factor β1 (TGF-β1), connective tissue growth factor (CTGF) and procollagen type I α-1 (COL1A1) luciferase reporter system to investigate the possible molecular mechanism of rapid-depolarization-induced atrial fibrosis. Mouse atrial fibroblasts were first transfected with promoter–luciferase reporters, and then co-cultured with HL-1 atrial myocytes. Rapid depolarization of atrial myocytes by rapid electrical field stimulation induced increased TGF-β1, CTGF and COL1A1 promoter activities in the co-cultured atrial fibroblasts (2.4 ± 0.3-fold increase, P= 0.008 for TGF-β1; 2.9 ± 0.4-fold increase, P< 0.001 for CTGF; and 2.1 ± 0.2-fold increase, P= 0.008 for COL1A1). Rapid depolarization of atrial myocytes increased paracrine secretion of angiotensin II (Ang II) and reactive oxygen species in the co-culture medium. Rapid electrical field stimulation-induced ROS generation in atrial myocytes was attenuated by the membrane NADPH oxidase inhibitor, apocynin. Atrial myocyte-induced expression of TGF-β1, CTGF and COL1A1 in atrial fibroblasts was attenuated by co-treatment with the Ang II receptor blocker, losartan, and apocynin. Atrial myocyte-induced COL1A1 expression in atrial fibroblasts was attenuated by anti-TGF-β1 antibody and RNA interference knockdown of the TGF-β1 receptor. We first demonstrated that tachycardia of atrial myocytes induced paracrine secretion of Ang II and reactive oxygen species, which in turn induced expression of CTGF and procollagen in co-cultured atrial fibroblasts through increasing TGF-β1 expression. The results may imply that use of an Ang II receptor blocker, in combination with an anti-oxidant, blocks rapid-depolarization-induced atrial fibrosis.